AIMC Topic: Drug Development

Clear Filters Showing 11 to 20 of 313 articles

Combining High-Throughput Screening and Machine Learning to Predict the Formation of Both Binary and Ternary Amorphous Solid Dispersion Formulations for Early Drug Discovery and Development.

Pharmaceutical research
OBJECTIVE: Amorphous solid dispersion (ASD) is widely utilized to enhance the solubility and bioavailability of water-insoluble drugs. However, conventional experimental approaches for ASD development are often resource-intensive and time-consuming. ...

Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning.

mAbs
Highly concentrated antibody solutions are necessary for developing subcutaneous injections but often exhibit high viscosities, posing challenges in antibody-drug development, manufacturing, and administration. Previous computational models were only...

The reality of modeling irritable bowel syndrome: progress and challenges.

Expert opinion on drug discovery
INTRODUCTION: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is often therapeutically challenging. While research has advanced our understanding of IBS pathophysiology, developing precise models to predict drug response and...

Embracing the changes and challenges with modern early drug discovery.

Expert opinion on drug discovery
INTRODUCTION: The landscape of early drug discovery is rapidly evolving, fueled by significant advancements in artificial intelligence (AI) and machine learning (ML), which are transforming the way drugs are discovered. As traditional drug discovery ...

Enhancing clinical trial outcome prediction with artificial intelligence: a systematic review.

Drug discovery today
Clinical trials are pivotal in drug development yet fraught with uncertainties and resource-intensive demands. The application of AI models to forecast trial outcomes could mitigate failures and expedite the drug discovery process. This review discus...

Applications of Artificial Intelligence in Drug Repurposing.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Drug repurposing identifies new therapeutic uses for the existing drugs originally developed for different indications, aiming at capitalizing on the established safety and efficacy profiles of known drugs. Thus, it is beneficial to bypass of early s...

SynthMol: A Drug Safety Prediction Framework Integrating Graph Attention and Molecular Descriptors into Pre-Trained Geometric Models.

Journal of chemical information and modeling
Drug safety is affected by multiple molecular properties and safety assessment is critical for clinical application. Evaluating a drug candidate's therapeutic potential is facilitated by machine learning models trained on extensive compound bioactivi...

Elevating Research and Careers in the Development of Safer Drugs through Artificial Intelligence.

Chemical research in toxicology
The session "Elevating Research and Careers in the Development of Safer Drugs through Artificial Intelligence," held at the American Chemical Society meeting, showcased innovative methodologies that AI brings to drug development, from predictive mode...

Advances of deep Neural Networks (DNNs) in the development of peptide drugs.

Future medicinal chemistry
Peptides are able to bind to difficult disease targets with high potency and specificity, providing great opportunities to meet unmet medical requirements. Nevertheless, the unique features of peptides, such as their small size, high structural flexi...

Future prospective of AI in drug discovery.

Advances in pharmacology (San Diego, Calif.)
Drug discovery and development is very expensive and long with an inferior success rate. It is quite inefficient and costly due to huge R&D costs and lower productivity in pharmaceutical industries, to discover effective drugs and their development. ...